This federal Project Grant award, worth $452,192, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The grant supports the "Development of Pan- and Phospho-Specific Nanobodies for Investigating MAPK and PP2A Signaling" project at Vanderbilt University. The research aims to enhance understanding of the reversible protein phosphorylation processes that regulate cellular homeostasis, with a focus on protein kinases and phosphatases. The award period runs from June 1, 2025 to March 31, 2029. Vanderbilt University, a leading private research institution, will conduct this comprehensive basic and translational biomedical research effort through its Sponsored Programs Administration division.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $452.2k | 5/14/25 |